Immunomedics (IMMU) Misses Q3 EPS by 6c

May 9, 2018 4:01 PM EDT

Immunomedics (NASDAQ: IMMU) reported Q3 EPS of ($0.21), $0.06 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $500 million, versus $1.3 million reported last year.

For earnings history and earnings-related data on Immunomedics (IMMU) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings